In the BioHarmony Drug Report Database

"Preview" Icon

Acamprosate

Campral (acamprosate) is a small molecule pharmaceutical. Acamprosate was first approved as Campral on 2004-07-29. It is used to treat alcoholism in the USA. It is known to target glutamate receptor ionotropic, NMDA 1 and gamma-aminobutyric acid receptor subunit alpha-1.

 

Trade Name

 

Campral
 

Common Name

 

acamprosate
 

ChEMBL ID

 

CHEMBL1201293
 

Indication

 

alcoholism
 

Drug Class

 

Image (chem structure or protein)

Acamprosate structure rendering